Psychotropic Drugs
PreclinicalSmall molecule
Psychotropic Drugs is one of 4 small molecule programs targeting Morbidity. It is currently in Preclinical.
1
Indications
3
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
5 competitors in Morbidity
#DrugCompanyPhaseTrials
1Cytosar
TevaPhase 2
Minipress
PfizerPreclinical
Luvox
SSolvay Pharmaceuticals
Preclinical
Psychotropic Drugs
UUniversity of Washington
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Psychotropic Drugs. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Washington